KRASG12C Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia.
Fujimoto K, Ikeda S, Tabata E, Kaneko T, Sagawa S, Yamada C, Kumagai K, Fukushima T, Haga S, Watanabe M, Muraoka T, Sekine A, Baba T, Ogura T.
Fujimoto K, et al. Among authors: muraoka t.
Cancers (Basel). 2024 Mar 28;16(7):1327. doi: 10.3390/cancers16071327.
Cancers (Basel). 2024.
PMID: 38611005
Free PMC article.
Review.